Last update 20 Mar 2025

Teslexivir

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
+ [2]
Target
HPV E1 x HPV E2
Action
inhibitors
Mechanism
HPV E1 inhibitors(HPV E1 inhibitors), HPV E2 inhibitors(HPV E2 inhibitors)
Therapeutic Areas
Infectious DiseasesSkin and Musculoskeletal DiseasesUrogenital Diseases
Active Indication
Condylomata Acuminata
Inactive Indication
Recurrent Respiratory Papillomatosis
Originator Organization
Aviragen TherapeuticsAviragen Therapeutics
Active Organization
Aviragen TherapeuticsAviragen Therapeutics
Inactive Organization
Vaxart, Inc.Vaxart, Inc.Anaconda Pharma SASUAnaconda Pharma SASU
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC35H36BrN3O4
InChIKeyIYWCUQWSZXLRNG-UHFFFAOYSA-N
CAS Registry1075798-37-6

Related

2
Clinical Trials associated with Teslexivir
NCT02724254
/ CompletedPhase 2
A Double-blind Placebo Controlled, Randomized, Phase II Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Topical Applications of AP611074 5% Gel for up to 16 Weeks in Condyloma Patients
NCT01532102
/ CompletedPhase 1/2
A Double-blind, Placebo Controlled, Randomized, Phase IIa Study to Assess the Safety, Tolerability, Efficacy, and Pharmacokinetics of Repeated Topical Applications Over 42 Days of AP611074 5% Gel in Condyloma Patients
100 Clinical Results associated with Teslexivir
Login to view more data
100 Translational Medicine associated with Teslexivir
Login to view more data
100 Patents (Medical) associated with Teslexivir
Login to view more data
100 Deals associated with Teslexivir
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Condylomata AcuminataPhase 2-
Aviragen TherapeuticsAviragen Therapeutics
-
Recurrent Respiratory PapillomatosisPhase 1
United States
Vaxart, Inc.Vaxart, Inc.
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free